Marcar este trabajo: estafa/spam - caducado - enlace roto - duplicar
Gilead Sciences is continuing to hire for all open roles. Our interview process may be conducted virtually and some roles will be asked to temporarily work from...
Marcar este trabajo: estafa/spam - caducado - enlace roto - duplicar
Jazz Pharmaceuticals is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningfu...
Marcar este trabajo: estafa/spam - caducado - enlace roto - duplicar
Seagen has submitted a Marketing Authorization Application to EMA for tucatinib,a highly selective tyrosine kinase inhibitor (TKI),for HER2+ metastatic breast c...
Marcar este trabajo: estafa/spam - caducado - enlace roto - duplicar
We are the Global Savings Group, the leading European Commerce Content platform focussing on the delivery of consumer rewards, cashback, savings opportunities, ...
Marcar este trabajo: estafa/spam - caducado - enlace roto - duplicar
About AbbVie AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomor...
Marcar este trabajo: estafa/spam - caducado - enlace roto - duplicar
Position Summary: Seagen has submitted a Marketing Authorization Application to EMA for tucatinib, a highly selective tyrosine kinase inhibitor (TKI), for HER2+...
Marcar este trabajo: estafa/spam - caducado - enlace roto - duplicar
Kite is continuing to hire for all open roles. Our interview process may be conducted virtually and some roles will be asked to temporarily work from home. Over...
Marcar este trabajo: estafa/spam - caducado - enlace roto - duplicar
DescriptionDescription Position Summary:Seagen has submitted a Marketing Authorization Application to EMA for tucatinib,a highly selective tyrosine kinase inhib...
Marcar este trabajo: estafa/spam - caducado - enlace roto - duplicar
In Global Development Medical Affairs Operations (GD MAO) in EMEA region we are currently looking for 3: Global Trial Leaders Focusing on 3 different Therapeuti...
